Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1091-1097

  Vinks, Alexander A T M M ^a,d   Mouton, Johan W ^b   Touw, Daan J ^a,e   Heijerman, Harry G M ^a   Danhof, Meindert ^c   Barker, Wim ^a  

^a LEYENBURG HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d Clinical Pharmacy   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LUNG INFECTION; MALE; PRIORITY JOURNAL;

EID: 0029991402     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1091     Document Type: Article

References (27)

1. Bakker, W., A. A. T. M. M. Vinks, J. W. Mouton, P. de Jonge, J. G. Verzijl, and H. G. M. Heijerman. 1993. Continuous intravenous treatment at home of respiratory tract infections with ceftazidime using a portable pump in cystic fibrosis patients; a multicentre study. Ned Tijdschr. Geneeskd 137: 2486-2491.
2. D'Argenio, D. Z. 1981 Optimal sampling times for pharmacokmetic experiments. J Pharmacokinet. Biopharm. 9:739-756
3. D'Argenio, D. Z., and A. Schumitzky. 1979 A program package for simulation and parameter estimation in pharmacokinetic systems. Comput. Programs Biomed. 9:115-134.
4. D'Argenio, D. Z., and A. Schumitzky. 1992 ADAPT II users guide. Biomedical Simulations Resource, University of Southern California, Los Angeles.
5. Dodge, W. F., R. W. Jelliffe, C. J. Richardson, R. A. Bellanger, J. A. Hokanson, and W. R. Snodgrass. 1993. Population pharmacokinetic models. Measures of central tendency Drug Invest. 5:206-211.
6. Drusano, G. L. 1991. Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination. J Clin. Pharmacol. 31:962-967.
7. Drusano, G. L., A. Forrest, K. Plaisance, and J. C. Wade. 1989. A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patients. Clin. Pharmacol. Ther. 45:635-641.
8. Drusano, G. L., A. Forrest, M. J. Snyder, M. D. Reed, and J. L. Blumer. 1988. An evaluation of optimal sampling strategy and adaptive study design. Clin. pharmacol. Ther. 44:232-238.
9. Du Bois, D., and E. F. Du Bois. 1916 A formula to estimate the appropriate surface area if height and weight are known. Arch Intern. Med 17:863-871.
10. Forrest, A., C. H. Ballow, D. E. Nix, M. C. Birmingham, and J. J. Schentag. 1993. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother. 37:1065-1072.
11. Hallynck, T. H., H. H. Soep, J. A. Thomis, J. Boelaert, and R. Daneels. 1981. Should clearance be normalized to body surface area or to lean body mass? Br. J. Clin. Pharmacol 11:523-525
12. Jelliffe, R. W., D. Z. D'Argenio, A. Schumitzky, L. Hu, and M. Liu. 1988. USC PC-PACK programs for planning, monitoring and adjusting drug dosage regimens, p 51 In Proceedings of the 23rd Annual Meeting of the Association for the Advancement of Medical Instrumentation, Washington, D C.
13. Jelliffe, R. W., P. Gomis, and A. Schumitzky. 1991 A population model of gentamicin made with a new nonparametric EM algorithm. Clin. Pharmacol Ther 49:153.
14. Jelliffe, R. W., T. Iglesias, A. K. Hurst, A. K. Foo, and J. Rodriguez. 1991. Individualizing gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies. Clin. Pharmacokinet. 21:461-478.
15. Jelliffe, R. W., and S. M. Jelliffe. 1972. A computer program for the estimation of creatinine clearance from unstable serum creatinine concentration. Math. Biosci. 14:17-24.
16. Jelliffe, R. W., A. Schumitzky, and M. Van Guilder. 1994. User manual for version 10.1 of the USC-PACK collection of PC programs. Laboratory of Applied Pharmacokinetics, University of Southern California School of Medicine, Los Angeles.
17. Jelliffe, R. W., A. Schumitzky, M. van Guilder, M. Liu, L. Hu, P. Maire, P. Gomis, X. Barbaut, and B. Tahani. 1993. Individualising drug dosage regimens roles of population pharmacokinetics and dynamic models. Bayesian fitting, and adaptive control Ther. Drug Monit. 15:380-393.
18. Mallet, A. 1986 A maximum likelihood estimation method for random coefficient regression models Biometrika 73:645-656
19. Mouton, J. W., A. M. Horrevorts, and M. F. Michel. 1992. Circadian rhythm of ceftazidime and meropenem serum levels during continuous infusion, p. 1016-1017. In H. Lode and D Adam (ed.), Proceedings of the International Congress of Chemotherapy: recent advances in chemotherapy. Futuramed Verlag, Munich.
20. Mouton, J. W., A. M. Horrevorts, S. E. Overbeek, K. F. Kerrebijn, and M. F. Michel. 1991. Pharmacokinetics of ceftazidime during continuous and intermittent infusion in cystic fibrosis patients, abstr. 88, p. 138. In Proceedings of the 17th European Cystic Fibrosis Conference, Copenhagen, Denmark.
21. Proost, J. H., and D. K. F. Meijer. 1992 MW/PHARM, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring Comput. Biol. Med. 22:155-163.
22. Schumitzky, A. 1991. Nonparametric EM algorithms for estimating prior distributions. Appl. Math. Comput. 45:143-157.
23. Sheiner, L. B., and S. L. Beal. 1981 Some suggestions for measuring predictive performance J. Pharmacokinet. Biopharm. 9:503-512.
24. Sheiner, L. B., B. Rosenberg, and V. V. Marathe. 1977. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data J Pharmacokinet. Biopharm. 5:445-479.
25. Steimer, J. L., A. Mallet, and F. Mentre. 1985 Estimating interindividual pharmacokinetic variability, p. 65-109 In M. Rowland et al. (ed.), Variability in drug therapy: description, estimation, and control. Raven Press, New York.
26. Vinks, A. A. T. M. M., D. J. Touw, H. G. M. Heijerman, M. Danhof, G. P. J. de Leede, and W. Bakker. 1993. Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home Ther. Drug Monit. 16:341-348.
27. Yuen, G. J., G. L. Drusano, A. Forrest, K. Plaisance, and E. S. Caplan. 1989. Prospective use of optimal sampling theory- steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients Clin. Pharmacol J. Ther. 46:451-457.